16 articles for M Nguyen
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.

Celera Genomics
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.

Mcgill University
Diphenyl ethers as androgen receptor antagonists for the topical suppression of sebum production.

Pfizer
Potent 4-amino-5-azaindole factor VIIa inhibitors.

Celera Genomics
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.

Celera Genomics
Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.

Chonnam National University
CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability.

Cv Therapeutics
New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.

Cv Therapeutics
High-throughput synthesis and optimization of thrombin inhibitors via urazole alpha-addition and Michael addition.

Molecumetics
Discovery and Structure-Activity Relationships of Novel Template, Truncated 1'-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators.

Seoul National University
Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.

Molecumetics
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8.

Janssen Research & Development
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators

Heptares Therapeutics
EIF4E-inhibiting compounds and methods

Effector Therapeutics
4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament

Boehringer Ingelheim International
Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.

Gilead Sciences